SCHEMBL1814045

SCHEMBL1814045

O=C(O)c1ccc(C#Cc2ccc(Cl)cc2)cc1

nearest known ligand 0.74

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.74
ALOX15 P16050 1/20 0.74
SRD5A2 P31213 3/20 0.65
RARB P10826 3/20 0.58
RARG P13631 3/20 0.58
PTPN11 Q06124 1/20 0.55
ALDH1A1 P00352 1/20 0.53
NR4A2 P43354 1/20 0.53
TP53 P04637 1/20 0.52
CES2 O00748 2/20 0.50
CES1 P23141 2/20 0.50
RARA P10276 2/20 0.50
RXRA P19793 1/20 0.48
RXRB P28702 1/20 0.48
CYP26A1 O43174 1/20 0.47
CYP3A4 P08684 1/20 0.47
CRABP2 P29373 1/20 0.47
CA1 P00915 1/20 0.46
CA2 P00918 1/20 0.46
NR4A1 P22736 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL69572 0.89 RARB (0.69) TSHRALOX15SRD5A2RARBRARG
SCHEMBL29789030 0.89 RARB (0.69) TSHRALOX15SRD5A2RARBRARG
Hydrochloric Acid SCHEMBL5666955 0.86 RARB (0.67) TSHRALOX15SRD5A2RARBRARG
4-Chloro-Benzoic Acid SCHEMBL28384 0.86 TSHR (1.00) TSHRALOX15SRD5A2ALDH1A1NR4A2
4-Chloro-Benzoic Acid SCHEMBL1331727 0.86 TSHR (1.00) TSHRALOX15SRD5A2ALDH1A1NR4A2
4-Chloro-Benzoic Acid SCHEMBL9493329 0.84 TSHR (0.94) TSHRALOX15SRD5A2ALDH1A1NR4A2
4-Chloro-Benzoic Acid SCHEMBL8024007 0.84 TSHR (0.94) TSHRALOX15SRD5A2ALDH1A1NR4A2
4-Chloro-Benzoic Acid SCHEMBL3150134 0.84 TSHR (0.94) TSHRALOX15SRD5A2ALDH1A1NR4A2
4-Chloro-Benzoic Acid SCHEMBL2918294 0.84 TSHR (0.94) TSHRALOX15SRD5A2ALDH1A1NR4A2
4-Chloro-Benzoic Acid SCHEMBL9316886 0.84 TSHR (0.94) TSHRALOX15SRD5A2ALDH1A1NR4A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1997638-B 1,1' - (1, 2-acetylenediyl) bis-benzene derivatives as PTP1-B inhibitors APPLIED RESEARCH SYSTEMS 2011-07-06 CN disclosed
US-7947851-B2 1,1′-(1,2-ethynediyl)bis-benzene derivatives as PTP 1-B inhibitors MERCK SERONO SA (CH) 2011-05-24 US disclosed
US-7947851-B2 1,1′-(1,2-ethynediyl)bis-benzene derivatives as PTP 1-B inhibitors MERCK SERONO SA (CH) 2011-05-24 US disclosed
US-20090029903-A1 1,1'-(1,2-Ethynediyl)Bis-Benzene Derivatives As Ptp 1-B Inhibitors MERCK SERONO SA (CH) 2009-01-29 US disclosed
US-20090029903-A1 1,1'-(1,2-Ethynediyl)Bis-Benzene Derivatives As Ptp 1-B Inhibitors MERCK SERONO SA (CH) 2009-01-29 US disclosed
CN-1997638-A 1, 1' - (1, 2-acetylenediyl) bis-benzene derivatives as PTP 1-B inhibitors APPLIED RESEARCH SYSTEMS (AN) 2007-07-11 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090029903-A1 1,1'-(1,2-Ethynediyl)Bis-Benzene Derivatives As Ptp 1-B Inhibitors PTPRS, PTPRZ1, PTP4A1 TSHR 2008/4885ALOX15 1375/4885SRD5A2 304/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.